CFTR and cystic fibrosis: This study also demonstrates that RFFL ASO treatment potentiated the effects of ETI on CFTR mutants associated with rare forms of CF, including those with limited responsiveness to modulators, such as R560S-CFTR, R347P-CFTR, and A561E-CFTR.